Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs
Guest: Krista (Oncology Nurse Navigator)
Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood
EPISODE SUMMARY
When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying twelve years of hospital vigils and treatment complications in her body — went in and requested her own testing.
What unfolds from that appointment is a story about what it actually takes to move through a healthcare system that doesn't know your mutation, that tells you the abnormality on your MRI is a lymph node, that sends you home with "come back in six months." Krista pushed for a biopsy that three specialists told her she didn't need. She was right. Her cancer diagnosis arrived two weeks before her scheduled preventive surgery. She now works as an oncology nurse navigator, walks patients through the same system she had to fight, and has built an educational platform for the hereditary cancer community — shaped entirely by what she wasn't told when she needed it most.
WE COVER
Testing too late, too little: Why Krista — a nurse with two generations of breast cancer in her family — was never offered genetic testing for twelve years, and what that delay meant for her outcomes.
The self-advocacy paradox: The tension of knowing something is wrong, having a medical background, identifying as a people-pleaser, and still having to push three specialists who said she was overreacting.
ATM mutation specifics: What carriers of ATM pathogenic variants actually face — including a 69% breast cancer risk, pancreatic and ovarian risk, and why the focus on BRCA leaves ATM carriers navigating without a map.
The middle phase nobody prepares you for: The psychological and bodily experience of bilateral mastectomy with flap reconstruction between the first and second surgery — including what it does to a woman's relationship with her own reflection.
Explaining hereditary cancer to children: How Krista told her daughters (ages 5, 8, and 10 at diagnosis) about her mutation, her surgery, and later her cancer — including what she had to process in herself first before she could speak from a calm place.
The grief that doesn't announce itself: How choosing surgery — a choice she felt grateful for — still produced grief she felt she wasn't allowed to have, and why "I chose this" doesn't close off mourning.
Cancer as identity reorganizer: How the experience shifted what Krista allows into her life, where she places her attention, and what felt insufficient about who she'd been before this began.
What the oncology system still misses: How even inside treatment, secondary risks (pancreatic, ovarian) get dropped after the primary intervention, and why mutation carriers need to track their full risk profile across specialties.
HIGHLIGHTS & TAKEAWAYS
Three specialists told her the abnormality wasn't cancer. She pushed anyway. That instinct — the unsettled feeling she couldn't explain — was the most accurate clinical information she had. Learning to trust it required overriding the authority gradient we're all trained to defer to.
The grief of choosing surgery is still grief. Knowing you're lucky, knowing you have options, knowing what you avoided — none of that neutralizes what it costs to look in the mirror at a body mid-reconstruction and not recognize yourself. Gratitude and loss occupy the same moment.
What she modeled for her daughters wasn't resilience. It was legibility — making the emotional experience visible and speakable so it could move through them instead of getting stored somewhere unnamed.
The shift from previvor to cancer diagnosis didn't happen at diagnosis. It had been accumulating across twelve years of watching her mother, then across the months of self-advocacy, then across a two-week window between a positive biopsy and surgery already on the calendar. The "before and after" is rarely a single moment.
She found her way into the hereditary cancer community not as someone who sought support, but as someone who had always been "fine." The connection she found there changed more than her career — it changed what she understood about what she'd actually needed all along.
CONTENT NOTE
This episode includes detailed discussion of a parent's cancer diagnosis and death, including end-of-life care and hospice. Krista also shares her own cancer diagnosis and surgical experience, including the psychological impact of bilateral mastectomy with reconstruction. The conversation includes reference to the loss of a sister-in-law to cancer at age 38.
RESOURCES MENTIONED
Guest resources:
Krista on Instagram: @cancer.prevention.coach — hereditary cancer education and advocacy content for the ATM and broader high-risk community
Standard links:
Face the Risk Together support groups: sarachampielcsw.com
FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org — national organization for hereditary cancer advocacy and peer support
National Society of Genetic Counselors (NSGC): nsgc.org — find a certified genetic counselor for hereditary cancer risk
CONNECT
If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @SaraChampieLCSW and sarachampielcsw.com for free resources and access to 1:1 and group support. You already speak this language — come walk the genetic line with us. Sara Champie